We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

90 hedge funds and large institutions have $167M invested in VanEck Biotech ETF in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

8% more funds holding

Funds holding: 83 → 90 (+7)

2% less call options, than puts

Call options by funds: $4.19M | Put options by funds: $4.28M

21% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 29

21.1% less ownership

Funds ownership: 45.23% → 24.14% (-21%)

43% less capital invested

Capital invested by funds: $294M → $167M (-$127M)

Holders
90
Holders Change
+7
Holders Change %
+8.43%
% of All Funds
2.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
23
Reduced
29
Closed
9
Calls
$4.19M
Puts
$4.28M
Net Calls
-$87K
Net Calls Change
+$2.9M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.67M
2
LPL Financial
LPL Financial
California
+$3.92M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.91M
4
Citadel Advisors
Citadel Advisors
Florida
+$3.87M
5
BPC
Banque Pictet & Cie
Switzerland
+$2.35M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$147M
2
CS
Credit Suisse
Switzerland
-$13.6M
3
TRCT
Tower Research Capital (TRC)
New York
-$3.49M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.08M
5
HF
HRT Financial
New York
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
ICAS
51
Investors Capital Advisory Services
Massachusetts
$323K -$66.2K -540 -18%
PTC
52
Private Trust Company
Ohio
$318K – – –
AB
53
Atlas Brown
Kentucky
$317K – – –
TH
54
Timber Hill
Connecticut
$295K -$51.2K -418 -15%
HF
55
HRT Financial
New York
$291K -$1.84M -15,054 -87%
DBIA
56
Dumont & Blake Investment Advisors
New Jersey
$289K – – –
SC
57
Scotia Capital
Ontario, Canada
$288K – – –
PNC Financial Services Group
58
PNC Financial Services Group
Pennsylvania
$284K +$17.4K +142 +7%
Brown Advisory
59
Brown Advisory
Maryland
$258K +$9.8K +80 +4%
BRWA
60
B. Riley Wealth Advisors
Florida
$253K +$243K +1,986 New
SBIA
61
Sheaff Brock Investment Advisors
Indiana
$241K +$233K +1,900 New
SIG
62
Stanford Investment Group
California
$213K +$490 +4 +0.2%
CB
63
Commerce Bank
Missouri
$209K +$202K +1,650 New
CA
64
Commerzbank Aktiengesellschaft
Germany
$208K +$201K +1,640 New
Bank of New York Mellon
65
Bank of New York Mellon
New York
$203K +$196K +1,599 New
PCMM
66
Private Capital Management (Minnesota)
Minnesota
$159K +$153K +1,250 New
Simplex Trading
67
Simplex Trading
Illinois
$147K +$142K +1,162 New
AFP
68
Ausdal Financial Partners
Iowa
$127K +$123K +1,003 New
OSNBOA
69
Old Second National Bank of Aurora
Illinois
$114K +$110K +895 New
HIIFS
70
Harel Insurance Investments & Financial Services
Israel
$105K +$102K +830 New
CLOS
71
Compagnie Lombard Odier SCmA
Switzerland
$101K – – –
CG
72
Colony Group
Massachusetts
$74K +$71.1K +580 New
WEC
73
Winslow Evans & Crocker
Massachusetts
$60.3K – – –
Bank of Montreal
74
Bank of Montreal
Ontario, Canada
$56K -$3.67K -30 -6%
BFEC
75
Benjamin F. Edwards & Company
Missouri
$48K – – –
1 2
3
4

BBH Hedge Fund Activity: Q4 2015 in Review

90 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2015, worth a combined $167M — down 43% from $294M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 9 closed out — a net gain of 7 holders — while 23 added to existing stakes and 29 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.67M. The largest seller was Goldman Sachs, cutting an estimated $147M.

  • 90 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2015, up from 83 in Q3 2015.
  • Funds reported $167M of VanEck Biotech ETF stock for Q4 2015, down 43% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q4 2015 and 9 closed out, a net change of +7 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2015 was Morgan Stanley, an estimated $5.67M added.
  • The largest VanEck Biotech ETF seller in Q4 2015 was Goldman Sachs, an estimated $147M sold.

Based on aggregated 13F filings for Q4 2015.